XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

ABSTRACT:

SUBMITTER: Nagasaka M 

PROVIDER: S-EPMC12432644 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature